Bo Ren
14Patents
5h-index
19Co-inventors
55Inventor score
Filing activity: Dec 31, 2011 → May 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9328111B2 | Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors | Chemistry; Metallurgy | 101 | Active |
| US9393232B2 | Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones | Emerging Cross-Sectional Technologies | 16 | Active |
| US11202782B2 | Treatment cancers using a combination comprising PARP inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9617273B2 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9260440B2 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10280163B2 | 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases | Human Necessities | 4 | Active |
| US10112952B2 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10457680B2 | Process for preparing a PARP inhibitor, crystalline forms, and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10501467B2 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10647714B2 | 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases | Human Necessities | 2 | Active |
| US10882856B2 | 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases | Human Necessities | 1 | Active |
| US9827226B2 | Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones | Emerging Cross-Sectional Technologies | 0 | Active |
| US12404517B2 | Rhizobial tRNA-derived small RNAs and uses thereof for regulating plant nodulation | Chemistry; Metallurgy | 0 | Active |
| US10823670B2 | Compact ultraviolet light adsorption sensing system | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.